Contact this trialFirst, we need to learn more about you.
Stem Cell Therapy
ST266 for Necrotizing Enterocolitis
Recruiting1 awardPhase 1 & 2
Orlando, Florida
This trial aims to test the safety and effectiveness of two different doses of ST266 given once a day through an IV to treat patients with Bell's stage IIA or higher NEC. The main goal is
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service